Feed LOGC
Summary
15 / 100 · Bulios Score
Valuation 17Growth 0Profitability 14Quality 2Debt 35Stability 34
What speaks for it
None of the indicators we track stands out on the positive side.
What to watch
- The company made a loss over the last 12 months.
- Repaying its net debt would take 264.5 years of operating profit.
- It passes only 1 of the 9 points of the Piotroski financial health test.
- It missed profit estimates 7 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
20212022202320242025
Diluted EPS (USD)
2021202220232024202520262027
- Analyst estimate
There is not enough revenue history yet to say how fast it grows.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $5.30M.
Profitability in detailIs it financially healthy?
Debt is a burdenCash and short-term investments $11.0M
Debt $209.4M
Free cash flow over 12 months -$30.6M
Over the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 3
- Hold 1
- Sell 0
No analyst has published a price target.
75% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2018By product
The company reports no revenue by product.
By region
- ISRAEL 100%
ISRAEL brings in 100% of revenue.
Segments in detail